Friday, Aug 17, 2018
engineered enzymes for better healthcare

优势

NeoScreenPak 具有众多优势。

  • 通过使用基于自主知识产权的单一测试平台,可筛检多达 7 种疾病
  • 测试操作简单-只需一个步骤,而不是竞争性产品所需的两个或更多个步骤
  • 测试可由经过培训的人员执行,无需精密的实验室设备,因此就可以在野外医院或偏远地区进行
  • 测试速度比最接近的竞争性产品快三倍,敏感度也更高。
  • 比市场上的其他产品更经济有效

技术                                优势                                渠道

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...